BioCentury | Aug 26, 2002
Company News

BioMarin, Glyko Biomedical Ltd. deal

...GBL. UBS Warburg was financial advisor to BMRN. BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Glyko...
BioCentury | Feb 11, 2002
Company News

BioMarin, Glyko Biomedical Ltd. deal

...11.4 million new BMRN shares to GBL stockholders. BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Glyko...
BioCentury | Nov 20, 2000
Company News

Glyko Biomedical Ltd. board of directors update

Glyko Biomedical Ltd. (TSE:GBL), Toronto, Ontario Business: Supply/Service Resigned: John Klock WIR Staff...
BioCentury | Jul 3, 2000
Company News

Glyko BioMedical Ltd. board of directors update

...Management, B9) Glyko BioMedical Ltd. (TSE:GBL; GLYK), Toronto, Ontario Business: Supply/Service Appointed: Joerg Gruber, chairman of...
BioCentury | Jul 3, 2000
Company News

Glyko BioMedical Ltd. management update

...Board, B8) Glyko BioMedical Ltd. (TSE:GBL; GLYK), Toronto, Ontario Business: Supply/Service Hired: Erich Sager as president...
BioCentury | May 10, 1999
Company News

BioMarin, Oxford GlycoSciences deal

...bought the biochemical reagent product line of Oxford GlycoScience (UK) Ltd., a subsidiary of OGS. Glyko...
BioCentury | Oct 12, 1998
Company News

BioMarin, Glyko Biomedical Ltd. deal

...BioMarin acquired GLYK subsidiary Glyko Inc. , a provider of carbohydrate enzyme analytical and diagnostic products, for...
...by BioMarin. The deal brings GLYK's ownership of BioMarin to 41.7 percent from 38 percent. Glyko Inc....
...Cambridge, Mass). Glyko will operate as a subsidiary of BioMarin. BioMarin Pharmaceutical Inc., Novato, Calif. Glyko...
BioCentury | Sep 21, 1998
Finance

The coming train wreck

...Inc. (NTEC, Horsham, Penn.), Cytel Corp. (CYTL, San Diego, Calif.), Biomira Inc. (BIOMF, Edmonton, Alberta), Glyko...
BioCentury | Apr 13, 1998
Company News

Glyko Biomedical Ltd. other research news

...to diagnose and monitor the progression of prostate cancer based on the company's FACE technology. Glyko...
BioCentury | Jan 26, 1998
Clinical News

Recombinant a-L-iduronidase: Phase I

Glyko Biomedical Ltd. (GLYK), Novato, Calif. Product: Recombinant a-L-iduronidase Indication: Repair deficiency of Hurler syndrome Status: BioMarin Pharmaceutical Inc. , which is 40 percent owned by GLYK, began a Phase I pivotal trial in 12 patients...
Items per page:
1 - 10 of 24
BioCentury | Aug 26, 2002
Company News

BioMarin, Glyko Biomedical Ltd. deal

...GBL. UBS Warburg was financial advisor to BMRN. BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Glyko...
BioCentury | Feb 11, 2002
Company News

BioMarin, Glyko Biomedical Ltd. deal

...11.4 million new BMRN shares to GBL stockholders. BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Glyko...
BioCentury | Nov 20, 2000
Company News

Glyko Biomedical Ltd. board of directors update

Glyko Biomedical Ltd. (TSE:GBL), Toronto, Ontario Business: Supply/Service Resigned: John Klock WIR Staff...
BioCentury | Jul 3, 2000
Company News

Glyko BioMedical Ltd. board of directors update

...Management, B9) Glyko BioMedical Ltd. (TSE:GBL; GLYK), Toronto, Ontario Business: Supply/Service Appointed: Joerg Gruber, chairman of...
BioCentury | Jul 3, 2000
Company News

Glyko BioMedical Ltd. management update

...Board, B8) Glyko BioMedical Ltd. (TSE:GBL; GLYK), Toronto, Ontario Business: Supply/Service Hired: Erich Sager as president...
BioCentury | May 10, 1999
Company News

BioMarin, Oxford GlycoSciences deal

...bought the biochemical reagent product line of Oxford GlycoScience (UK) Ltd., a subsidiary of OGS. Glyko...
BioCentury | Oct 12, 1998
Company News

BioMarin, Glyko Biomedical Ltd. deal

...BioMarin acquired GLYK subsidiary Glyko Inc. , a provider of carbohydrate enzyme analytical and diagnostic products, for...
...by BioMarin. The deal brings GLYK's ownership of BioMarin to 41.7 percent from 38 percent. Glyko Inc....
...Cambridge, Mass). Glyko will operate as a subsidiary of BioMarin. BioMarin Pharmaceutical Inc., Novato, Calif. Glyko...
BioCentury | Sep 21, 1998
Finance

The coming train wreck

...Inc. (NTEC, Horsham, Penn.), Cytel Corp. (CYTL, San Diego, Calif.), Biomira Inc. (BIOMF, Edmonton, Alberta), Glyko...
BioCentury | Apr 13, 1998
Company News

Glyko Biomedical Ltd. other research news

...to diagnose and monitor the progression of prostate cancer based on the company's FACE technology. Glyko...
BioCentury | Jan 26, 1998
Clinical News

Recombinant a-L-iduronidase: Phase I

Glyko Biomedical Ltd. (GLYK), Novato, Calif. Product: Recombinant a-L-iduronidase Indication: Repair deficiency of Hurler syndrome Status: BioMarin Pharmaceutical Inc. , which is 40 percent owned by GLYK, began a Phase I pivotal trial in 12 patients...
Items per page:
1 - 10 of 24